Trial Profile
Phase II study of SKP-2075 (fluticasone/theophylline) in patients with COPD
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 20 Aug 2015
Price :
$35
*
At a glance
- Drugs Fluticasone/theophylline (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Adverse reactions; Therapeutic Use
- Sponsors SkyePharma PLC
- 20 Aug 2015 New trial record